Ali McBride, PharmD, MS, BCOP, discussed during the recent National Oncology Conference his goals for ACCC while serving as president, which include focusing on education, innovation, and compensation.<br />
Ali McBride, PharmD, MS, BCOP, president, Association of Community Cancer Centers (ACCC), and clinical coordinator, Hematology/Oncology, the University of Arizona Cancer Center, discussed during the recent National Oncology Conference his goals for ACCC while serving as president, which include focusing on education, innovation, and compensation.
Compensation is often not measured across the continuum of care, which makes it an important focus in the ACCC. In cancer care today, alternative payment models and oncology care models are popular themes, and the common denominator is the understanding of which people play a role in patient care within cancer centers. The care team can include physicians, nutritionists, pharmacists, nurse navigators, triage nurses, and advanced practitioners. Together, these clinicians create an environment of collaborative care in which there are multiple point persons.
Having a clear picture of which people are involved in care is important for both the patient and care team because these are the individuals monitoring the patient’s treatment and ultimately driving the future of oncology care models.
SELECT Trial Establishes Lenvatinib’s Role in RAI-Refractory DTC
May 2nd 2024In an interview with Targeted Oncology, Lori J. Wirth, MD, delved into how the data from SELECT signals lenvatinib effectiveness as a frontline therapy for patients with RAI-refractory differentiated thyroid cancer.
Read More
Landgren on MRD as an End Point for Multiple Myeloma Trials
May 1st 2024C. Ola Landgren, MD, PhD, discussed the FDA’s unanimous ODAC vote supporting minimal residual disease as an accelerated approval end point in multiple myeloma and the implications of this vote in the myeloma research field.
Read More